Paradigm Asset Management Co. LLC Sells 100 Shares of Intuitive Surgical, Inc. $ISRG

Paradigm Asset Management Co. LLC lessened its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 25.0% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 300 shares of the medical equipment provider’s stock after selling 100 shares during the quarter. Paradigm Asset Management Co. LLC’s holdings in Intuitive Surgical were worth $163,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of ISRG. Vanguard Group Inc. lifted its position in shares of Intuitive Surgical by 1.4% during the 1st quarter. Vanguard Group Inc. now owns 32,665,531 shares of the medical equipment provider’s stock valued at $16,178,258,000 after buying an additional 453,335 shares during the last quarter. Invesco Ltd. raised its stake in Intuitive Surgical by 1.7% in the 1st quarter. Invesco Ltd. now owns 4,219,974 shares of the medical equipment provider’s stock valued at $2,090,027,000 after acquiring an additional 71,794 shares during the period. Northern Trust Corp lifted its holdings in Intuitive Surgical by 0.3% during the first quarter. Northern Trust Corp now owns 3,631,281 shares of the medical equipment provider’s stock valued at $1,798,465,000 after purchasing an additional 11,988 shares during the last quarter. Wellington Management Group LLP boosted its position in Intuitive Surgical by 15.0% during the first quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider’s stock worth $1,732,975,000 after purchasing an additional 457,080 shares during the period. Finally, Nuveen LLC purchased a new position in shares of Intuitive Surgical in the first quarter worth about $1,715,899,000. 83.64% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of brokerages recently commented on ISRG. UBS Group set a $600.00 price target on shares of Intuitive Surgical and gave the company a “neutral” rating in a research note on Thursday, October 23rd. Deutsche Bank Aktiengesellschaft reissued a “sell” rating on shares of Intuitive Surgical in a report on Friday, August 22nd. Leerink Partners raised their price target on Intuitive Surgical from $593.00 to $600.00 and gave the stock an “outperform” rating in a report on Wednesday, October 22nd. HSBC boosted their price objective on Intuitive Surgical from $595.00 to $644.00 and gave the company a “buy” rating in a research note on Thursday, October 23rd. Finally, Jefferies Financial Group lifted their target price on Intuitive Surgical from $550.00 to $560.00 and gave the company a “hold” rating in a report on Wednesday, October 22nd. Two investment analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus price target of $608.92.

Insiders Place Their Bets

In other news, CEO David J. Rosa sold 24,500 shares of the stock in a transaction on Friday, October 24th. The shares were sold at an average price of $547.55, for a total value of $13,414,975.00. Following the transaction, the chief executive officer owned 234,256 shares of the company’s stock, valued at $128,266,872.80. This represents a 9.47% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider Gary S. Guthart sold 29,360 shares of Intuitive Surgical stock in a transaction on Friday, August 29th. The stock was sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the sale, the insider directly owned 19,827 shares of the company’s stock, valued at $9,368,059.23. This represents a 59.69% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders have sold 98,078 shares of company stock worth $51,445,892. 0.70% of the stock is owned by corporate insiders.

Intuitive Surgical Stock Up 2.2%

Shares of NASDAQ ISRG opened at $560.00 on Friday. The stock’s 50-day simple moving average is $471.89 and its two-hundred day simple moving average is $501.02. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $616.00. The firm has a market capitalization of $200.75 billion, a P/E ratio of 74.07, a P/E/G ratio of 4.94 and a beta of 1.62.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, topping the consensus estimate of $1.99 by $0.41. The company had revenue of $2.51 billion during the quarter, compared to analyst estimates of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.Intuitive Surgical’s revenue was up 22.9% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.84 earnings per share. As a group, research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.